Stay up to date with the latest research, tips, and trends in fitness, nutrition, and weight management.
Polycystic Ovary Syndrome has been renamed Polyendocrine Metabolic Ovarian Syndrome. Read more about the landmark global consensus.
Duchenne Parent Project Spain is investing €247,000 in a project to create a new laboratory model to study heart health in DMD and BMD.
First-line therapies for H. pylori, a new assessment to measure gluten exposure in children, and hypnosis for women with primary biliary cholangitis and fatigue are among the topics tackled in the May issue of AJG
A woman diagnosed with high blood pressure has urged everyone in Kilkenny to get theirs checked
The findings suggest that people with bronchiectasis who also have chronic sinus disease may be more likely to have Pseudomonas aeruginosa, a bacteria that can make lung disease harder to treat.
In the latest report of a potential case, Italy's ANSA news agency said a 25-year-old Italian man who had flown on a KLM flight with a woman who died of hantavirus had been taken to hospital with symptom
The British Safety Council details the ongoing health risks posed by asbestos, including how these are impacted by a changing climate
Steven M. Horwitz, MD, discussed the PRIMO dosing strategy to manage adverse effects in lymphoma.
WashU researchers led a population-based study of thousands of college students showing that a phone app with text coaching increased access to care and eased symptoms of depression, anxiety and eating disorders.
Polyendocrine Metabolic Ovarian Syndrome (PMOS) is the new name for the condition previously known as Polycystic Ovary Syndrome (PCOS), which impacts 1 in 8, or more than 170 million women worldwide.